カテゴリー： Market Monitor Global, 世界, 医療/バイオ

経口レボチロキシンナトリウムの世界市場見通し2023年-2029年

◆英語タイトル：Oral Levothyroxine Sodium Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5844）

◆商品コード：MMG23JU5844
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：73
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Oral Levothyroxine Sodium Market 調査レポートは次の情報を含め、グローバルにおけるの経口レボチロキシンナトリウム市場規模と予測を収録しています。・世界の経口レボチロキシンナトリウム市場：売上、2018年-2023年、2024年-2029年
・世界の経口レボチロキシンナトリウム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の経口レボチロキシンナトリウム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「25μg」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

経口レボチロキシンナトリウムのグローバル主要企業は、Abbvie、 Mylan Pharma、 Merck、 Pfizer、 Lannett Company、 Novartis、 IBSA、 Piramal Critical Care、 Abbottなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、経口レボチロキシンナトリウムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の経口レボチロキシンナトリウム市場：タイプ別、2018年-2023年、2024年-2029年
世界の経口レボチロキシンナトリウム市場：タイプ別市場シェア、2022年
・25μg、50μg、75μg、その他

世界の経口レボチロキシンナトリウム市場：用途別、2018年-2023年、2024年-2029年
世界の経口レボチロキシンナトリウム市場：用途別市場シェア、2022年
・薬局、病院、その他

世界の経口レボチロキシンナトリウム市場：地域・国別、2018年-2023年、2024年-2029年
世界の経口レボチロキシンナトリウム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における経口レボチロキシンナトリウムのグローバル売上、2018年-2023年
・主要企業における経口レボチロキシンナトリウムのグローバル売上シェア、2022年
・主要企業における経口レボチロキシンナトリウムのグローバル販売量、2018年-2023年
・主要企業における経口レボチロキシンナトリウムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Abbvie、 Mylan Pharma、 Merck、 Pfizer、 Lannett Company、 Novartis、 IBSA、 Piramal Critical Care、 Abbott

*************************************************************

・調査・分析レポートの概要
経口レボチロキシンナトリウム市場の定義
市場セグメント
世界の経口レボチロキシンナトリウム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の経口レボチロキシンナトリウム市場規模
世界の経口レボチロキシンナトリウム市場規模：2022年 VS 2029年
世界の経口レボチロキシンナトリウム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの経口レボチロキシンナトリウムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の経口レボチロキシンナトリウム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：25μg、50μg、75μg、その他
経口レボチロキシンナトリウムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：薬局、病院、その他
経口レボチロキシンナトリウムの用途別グローバル売上・予測

・地域別市場分析
地域別経口レボチロキシンナトリウム市場規模 2022年と2029年
地域別経口レボチロキシンナトリウム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Abbvie、 Mylan Pharma、 Merck、 Pfizer、 Lannett Company、 Novartis、 IBSA、 Piramal Critical Care、 Abbott
...

Levothyroxine is used to treat an underactive thyroid gland (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery.
This report aims to provide a comprehensive presentation of the global market for Oral Levothyroxine Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Levothyroxine Sodium. This report contains market size and forecasts of Oral Levothyroxine Sodium in global, including the following market information:
Global Oral Levothyroxine Sodium Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Oral Levothyroxine Sodium Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Oral Levothyroxine Sodium companies in 2022 (%)
The global Oral Levothyroxine Sodium market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
25 mcg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oral Levothyroxine Sodium include Abbvie, Mylan Pharma, Merck, Pfizer, Lannett Company, Novartis, IBSA, Piramal Critical Care and Abbott, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Levothyroxine Sodium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Levothyroxine Sodium Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral Levothyroxine Sodium Market Segment Percentages, by Type, 2022 (%)
25 mcg
50 mcg
75 mcg
Others
Global Oral Levothyroxine Sodium Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral Levothyroxine Sodium Market Segment Percentages, by Application, 2022 (%)
Pharmacy
Hospital
Others
Global Oral Levothyroxine Sodium Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral Levothyroxine Sodium Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Levothyroxine Sodium revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oral Levothyroxine Sodium revenues share in global market, 2022 (%)
Key companies Oral Levothyroxine Sodium sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Oral Levothyroxine Sodium sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Mylan Pharma
Merck
Pfizer
Lannett Company
Novartis
IBSA
Piramal Critical Care
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Levothyroxine Sodium, market overview.
Chapter 2: Global Oral Levothyroxine Sodium market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Levothyroxine Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Levothyroxine Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Levothyroxine Sodium capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Oral Levothyroxine Sodium Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Levothyroxine Sodium Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Levothyroxine Sodium Overall Market Size
2.1 Global Oral Levothyroxine Sodium Market Size: 2022 VS 2029
2.2 Global Oral Levothyroxine Sodium Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Oral Levothyroxine Sodium Sales: 2018-2029
3 Company Landscape
3.1 Top Oral Levothyroxine Sodium Players in Global Market
3.2 Top Global Oral Levothyroxine Sodium Companies Ranked by Revenue
3.3 Global Oral Levothyroxine Sodium Revenue by Companies
3.4 Global Oral Levothyroxine Sodium Sales by Companies
3.5 Global Oral Levothyroxine Sodium Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oral Levothyroxine Sodium Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oral Levothyroxine Sodium Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Levothyroxine Sodium Players in Global Market
3.8.1 List of Global Tier 1 Oral Levothyroxine Sodium Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Levothyroxine Sodium Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Oral Levothyroxine Sodium Market Size Markets, 2022 & 2029
4.1.2 25 mcg
4.1.3 50 mcg
4.1.4 75 mcg
4.1.5 Others
4.2 By Type – Global Oral Levothyroxine Sodium Revenue & Forecasts
4.2.1 By Type – Global Oral Levothyroxine Sodium Revenue, 2018-2023
4.2.2 By Type – Global Oral Levothyroxine Sodium Revenue, 2024-2029
4.2.3 By Type – Global Oral Levothyroxine Sodium Revenue Market Share, 2018-2029
4.3 By Type – Global Oral Levothyroxine Sodium Sales & Forecasts
4.3.1 By Type – Global Oral Levothyroxine Sodium Sales, 2018-2023
4.3.2 By Type – Global Oral Levothyroxine Sodium Sales, 2024-2029
4.3.3 By Type – Global Oral Levothyroxine Sodium Sales Market Share, 2018-2029
4.4 By Type – Global Oral Levothyroxine Sodium Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oral Levothyroxine Sodium Market Size, 2022 & 2029
5.1.2 Pharmacy
5.1.3 Hospital
5.1.4 Others
5.2 By Application – Global Oral Levothyroxine Sodium Revenue & Forecasts
5.2.1 By Application – Global Oral Levothyroxine Sodium Revenue, 2018-2023
5.2.2 By Application – Global Oral Levothyroxine Sodium Revenue, 2024-2029
5.2.3 By Application – Global Oral Levothyroxine Sodium Revenue Market Share, 2018-2029
5.3 By Application – Global Oral Levothyroxine Sodium Sales & Forecasts
5.3.1 By Application – Global Oral Levothyroxine Sodium Sales, 2018-2023
5.3.2 By Application – Global Oral Levothyroxine Sodium Sales, 2024-2029
5.3.3 By Application – Global Oral Levothyroxine Sodium Sales Market Share, 2018-2029
5.4 By Application – Global Oral Levothyroxine Sodium Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Oral Levothyroxine Sodium Market Size, 2022 & 2029
6.2 By Region – Global Oral Levothyroxine Sodium Revenue & Forecasts
6.2.1 By Region – Global Oral Levothyroxine Sodium Revenue, 2018-2023
6.2.2 By Region – Global Oral Levothyroxine Sodium Revenue, 2024-2029
6.2.3 By Region – Global Oral Levothyroxine Sodium Revenue Market Share, 2018-2029
6.3 By Region – Global Oral Levothyroxine Sodium Sales & Forecasts
6.3.1 By Region – Global Oral Levothyroxine Sodium Sales, 2018-2023
6.3.2 By Region – Global Oral Levothyroxine Sodium Sales, 2024-2029
6.3.3 By Region – Global Oral Levothyroxine Sodium Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Oral Levothyroxine Sodium Revenue, 2018-2029
6.4.2 By Country – North America Oral Levothyroxine Sodium Sales, 2018-2029
6.4.3 US Oral Levothyroxine Sodium Market Size, 2018-2029
6.4.4 Canada Oral Levothyroxine Sodium Market Size, 2018-2029
6.4.5 Mexico Oral Levothyroxine Sodium Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Oral Levothyroxine Sodium Revenue, 2018-2029
6.5.2 By Country – Europe Oral Levothyroxine Sodium Sales, 2018-2029
6.5.3 Germany Oral Levothyroxine Sodium Market Size, 2018-2029
6.5.4 France Oral Levothyroxine Sodium Market Size, 2018-2029
6.5.5 U.K. Oral Levothyroxine Sodium Market Size, 2018-2029
6.5.6 Italy Oral Levothyroxine Sodium Market Size, 2018-2029
6.5.7 Russia Oral Levothyroxine Sodium Market Size, 2018-2029
6.5.8 Nordic Countries Oral Levothyroxine Sodium Market Size, 2018-2029
6.5.9 Benelux Oral Levothyroxine Sodium Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Oral Levothyroxine Sodium Revenue, 2018-2029
6.6.2 By Region – Asia Oral Levothyroxine Sodium Sales, 2018-2029
6.6.3 China Oral Levothyroxine Sodium Market Size, 2018-2029
6.6.4 Japan Oral Levothyroxine Sodium Market Size, 2018-2029
6.6.5 South Korea Oral Levothyroxine Sodium Market Size, 2018-2029
6.6.6 Southeast Asia Oral Levothyroxine Sodium Market Size, 2018-2029
6.6.7 India Oral Levothyroxine Sodium Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Oral Levothyroxine Sodium Revenue, 2018-2029
6.7.2 By Country – South America Oral Levothyroxine Sodium Sales, 2018-2029
6.7.3 Brazil Oral Levothyroxine Sodium Market Size, 2018-2029
6.7.4 Argentina Oral Levothyroxine Sodium Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Oral Levothyroxine Sodium Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Oral Levothyroxine Sodium Sales, 2018-2029
6.8.3 Turkey Oral Levothyroxine Sodium Market Size, 2018-2029
6.8.4 Israel Oral Levothyroxine Sodium Market Size, 2018-2029
6.8.5 Saudi Arabia Oral Levothyroxine Sodium Market Size, 2018-2029
6.8.6 UAE Oral Levothyroxine Sodium Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbvie
7.1.1 Abbvie Company Summary
7.1.2 Abbvie Business Overview
7.1.3 Abbvie Oral Levothyroxine Sodium Major Product Offerings
7.1.4 Abbvie Oral Levothyroxine Sodium Sales and Revenue in Global (2018-2023)
7.1.5 Abbvie Key News & Latest Developments
7.2 Mylan Pharma
7.2.1 Mylan Pharma Company Summary
7.2.2 Mylan Pharma Business Overview
7.2.3 Mylan Pharma Oral Levothyroxine Sodium Major Product Offerings
7.2.4 Mylan Pharma Oral Levothyroxine Sodium Sales and Revenue in Global (2018-2023)
7.2.5 Mylan Pharma Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Oral Levothyroxine Sodium Major Product Offerings
7.3.4 Merck Oral Levothyroxine Sodium Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Oral Levothyroxine Sodium Major Product Offerings
7.4.4 Pfizer Oral Levothyroxine Sodium Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Lannett Company
7.5.1 Lannett Company Company Summary
7.5.2 Lannett Company Business Overview
7.5.3 Lannett Company Oral Levothyroxine Sodium Major Product Offerings
7.5.4 Lannett Company Oral Levothyroxine Sodium Sales and Revenue in Global (2018-2023)
7.5.5 Lannett Company Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Oral Levothyroxine Sodium Major Product Offerings
7.6.4 Novartis Oral Levothyroxine Sodium Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 IBSA
7.7.1 IBSA Company Summary
7.7.2 IBSA Business Overview
7.7.3 IBSA Oral Levothyroxine Sodium Major Product Offerings
7.7.4 IBSA Oral Levothyroxine Sodium Sales and Revenue in Global (2018-2023)
7.7.5 IBSA Key News & Latest Developments
7.8 Piramal Critical Care
7.8.1 Piramal Critical Care Company Summary
7.8.2 Piramal Critical Care Business Overview
7.8.3 Piramal Critical Care Oral Levothyroxine Sodium Major Product Offerings
7.8.4 Piramal Critical Care Oral Levothyroxine Sodium Sales and Revenue in Global (2018-2023)
7.8.5 Piramal Critical Care Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Oral Levothyroxine Sodium Major Product Offerings
7.9.4 Abbott Oral Levothyroxine Sodium Sales and Revenue in Global (2018-2023)
7.9.5 Abbott Key News & Latest Developments
8 Global Oral Levothyroxine Sodium Production Capacity, Analysis
8.1 Global Oral Levothyroxine Sodium Production Capacity, 2018-2029
8.2 Oral Levothyroxine Sodium Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Levothyroxine Sodium Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Levothyroxine Sodium Supply Chain Analysis
10.1 Oral Levothyroxine Sodium Industry Value Chain
10.2 Oral Levothyroxine Sodium Upstream Market
10.3 Oral Levothyroxine Sodium Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Levothyroxine Sodium Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Oral Levothyroxine Sodium in Global Market
Table 2. Top Oral Levothyroxine Sodium Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Oral Levothyroxine Sodium Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Oral Levothyroxine Sodium Revenue Share by Companies, 2018-2023
Table 5. Global Oral Levothyroxine Sodium Sales by Companies, (K Units), 2018-2023
Table 6. Global Oral Levothyroxine Sodium Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Oral Levothyroxine Sodium Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Oral Levothyroxine Sodium Product Type
Table 9. List of Global Tier 1 Oral Levothyroxine Sodium Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Levothyroxine Sodium Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Oral Levothyroxine Sodium Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Oral Levothyroxine Sodium Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Oral Levothyroxine Sodium Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Oral Levothyroxine Sodium Sales (K Units), 2018-2023
Table 15. By Type - Global Oral Levothyroxine Sodium Sales (K Units), 2024-2029
Table 16. By Application – Global Oral Levothyroxine Sodium Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Oral Levothyroxine Sodium Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Oral Levothyroxine Sodium Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Oral Levothyroxine Sodium Sales (K Units), 2018-2023
Table 20. By Application - Global Oral Levothyroxine Sodium Sales (K Units), 2024-2029
Table 21. By Region – Global Oral Levothyroxine Sodium Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Oral Levothyroxine Sodium Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Oral Levothyroxine Sodium Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Oral Levothyroxine Sodium Sales (K Units), 2018-2023
Table 25. By Region - Global Oral Levothyroxine Sodium Sales (K Units), 2024-2029
Table 26. By Country - North America Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Oral Levothyroxine Sodium Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Oral Levothyroxine Sodium Sales, (K Units), 2018-2023
Table 29. By Country - North America Oral Levothyroxine Sodium Sales, (K Units), 2024-2029
Table 30. By Country - Europe Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Oral Levothyroxine Sodium Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Oral Levothyroxine Sodium Sales, (K Units), 2018-2023
Table 33. By Country - Europe Oral Levothyroxine Sodium Sales, (K Units), 2024-2029
Table 34. By Region - Asia Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Oral Levothyroxine Sodium Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Oral Levothyroxine Sodium Sales, (K Units), 2018-2023
Table 37. By Region - Asia Oral Levothyroxine Sodium Sales, (K Units), 2024-2029
Table 38. By Country - South America Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Oral Levothyroxine Sodium Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Oral Levothyroxine Sodium Sales, (K Units), 2018-2023
Table 41. By Country - South America Oral Levothyroxine Sodium Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Oral Levothyroxine Sodium Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Oral Levothyroxine Sodium Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Oral Levothyroxine Sodium Sales, (K Units), 2024-2029
Table 46. Abbvie Company Summary
Table 47. Abbvie Oral Levothyroxine Sodium Product Offerings
Table 48. Abbvie Oral Levothyroxine Sodium Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Abbvie Key News & Latest Developments
Table 50. Mylan Pharma Company Summary
Table 51. Mylan Pharma Oral Levothyroxine Sodium Product Offerings
Table 52. Mylan Pharma Oral Levothyroxine Sodium Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Mylan Pharma Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Oral Levothyroxine Sodium Product Offerings
Table 56. Merck Oral Levothyroxine Sodium Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Oral Levothyroxine Sodium Product Offerings
Table 60. Pfizer Oral Levothyroxine Sodium Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Lannett Company Company Summary
Table 63. Lannett Company Oral Levothyroxine Sodium Product Offerings
Table 64. Lannett Company Oral Levothyroxine Sodium Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Lannett Company Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Oral Levothyroxine Sodium Product Offerings
Table 68. Novartis Oral Levothyroxine Sodium Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. IBSA Company Summary
Table 71. IBSA Oral Levothyroxine Sodium Product Offerings
Table 72. IBSA Oral Levothyroxine Sodium Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. IBSA Key News & Latest Developments
Table 74. Piramal Critical Care Company Summary
Table 75. Piramal Critical Care Oral Levothyroxine Sodium Product Offerings
Table 76. Piramal Critical Care Oral Levothyroxine Sodium Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Piramal Critical Care Key News & Latest Developments
Table 78. Abbott Company Summary
Table 79. Abbott Oral Levothyroxine Sodium Product Offerings
Table 80. Abbott Oral Levothyroxine Sodium Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Abbott Key News & Latest Developments
Table 82. Oral Levothyroxine Sodium Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Oral Levothyroxine Sodium Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Oral Levothyroxine Sodium Production by Region, 2018-2023 (K Units)
Table 85. Global Oral Levothyroxine Sodium Production by Region, 2024-2029 (K Units)
Table 86. Oral Levothyroxine Sodium Market Opportunities & Trends in Global Market
Table 87. Oral Levothyroxine Sodium Market Drivers in Global Market
Table 88. Oral Levothyroxine Sodium Market Restraints in Global Market
Table 89. Oral Levothyroxine Sodium Raw Materials
Table 90. Oral Levothyroxine Sodium Raw Materials Suppliers in Global Market
Table 91. Typical Oral Levothyroxine Sodium Downstream
Table 92. Oral Levothyroxine Sodium Downstream Clients in Global Market
Table 93. Oral Levothyroxine Sodium Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oral Levothyroxine Sodium Segment by Type in 2022
Figure 2. Oral Levothyroxine Sodium Segment by Application in 2022
Figure 3. Global Oral Levothyroxine Sodium Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oral Levothyroxine Sodium Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oral Levothyroxine Sodium Revenue, 2018-2029 (US$, Mn)
Figure 7. Oral Levothyroxine Sodium Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Oral Levothyroxine Sodium Revenue in 2022
Figure 9. By Type - Global Oral Levothyroxine Sodium Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Oral Levothyroxine Sodium Revenue Market Share, 2018-2029
Figure 11. By Type - Global Oral Levothyroxine Sodium Sales Market Share, 2018-2029
Figure 12. By Type - Global Oral Levothyroxine Sodium Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Oral Levothyroxine Sodium Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Oral Levothyroxine Sodium Revenue Market Share, 2018-2029
Figure 15. By Application - Global Oral Levothyroxine Sodium Sales Market Share, 2018-2029
Figure 16. By Application - Global Oral Levothyroxine Sodium Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Oral Levothyroxine Sodium Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Oral Levothyroxine Sodium Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Oral Levothyroxine Sodium Revenue Market Share, 2018-2029
Figure 20. By Region - Global Oral Levothyroxine Sodium Sales Market Share, 2018-2029
Figure 21. By Country - North America Oral Levothyroxine Sodium Revenue Market Share, 2018-2029
Figure 22. By Country - North America Oral Levothyroxine Sodium Sales Market Share, 2018-2029
Figure 23. US Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Oral Levothyroxine Sodium Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Oral Levothyroxine Sodium Sales Market Share, 2018-2029
Figure 28. Germany Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 29. France Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Oral Levothyroxine Sodium Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Oral Levothyroxine Sodium Sales Market Share, 2018-2029
Figure 37. China Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 41. India Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Oral Levothyroxine Sodium Revenue Market Share, 2018-2029
Figure 43. By Country - South America Oral Levothyroxine Sodium Sales Market Share, 2018-2029
Figure 44. Brazil Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Oral Levothyroxine Sodium Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Oral Levothyroxine Sodium Sales Market Share, 2018-2029
Figure 48. Turkey Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Oral Levothyroxine Sodium Revenue, (US$, Mn), 2018-2029
Figure 52. Global Oral Levothyroxine Sodium Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Oral Levothyroxine Sodium by Region, 2022 VS 2029
Figure 54. Oral Levothyroxine Sodium Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 経口レボチロキシンナトリウムの世界市場見通し2023年-2029年(Oral Levothyroxine Sodium Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

経口レボチロキシンナトリウムの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp